发明名称 |
Medicament for influencing intra=ocular pressure and treating myopia - comprises cells isolated from the iris of vertebrate(s) |
摘要 |
Medicament for influencing intraocular pressure comprises components (I) of (C) Kogan egg cells. Isolation of ascorbic acid (II), (I) or a halocrine incretion (III) from the eyes up vertebrates comprises: (a) either sepg. the front quarter of the eyeball (consisting of the iris, the cornea, the aq. humour and a part of the lens) from the rest of the eyeball, or making an incision in the cornea; (b) removing the iris and the aq. humour; (c) squeezing out the tissue fluids in the iris/aq. humour, to give (III) (which contains (I)) and (I) (which is present in the aq. humour. USE/ADVANTAGE - Esp. used for treatment of progressive short-sightedness in young people and elevated ocular pressure in older people
|
申请公布号 |
DE4207366(A1) |
申请公布日期 |
1993.04.08 |
申请号 |
DE19924207366 |
申请日期 |
1992.03.05 |
申请人 |
OBAL, ADALBERT, DR.MED., 1000 BERLIN, DE |
发明人 |
OBAL, ADALBERT, DR.MED., 1000 BERLIN, DE |
分类号 |
A61K35/44 |
主分类号 |
A61K35/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|